Picture of European Medical Solutions SA logo

ALEMS — European Medical Solutions SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: ASIT Biotech Announces Publication of Study of Lead Product For Grass Pollen Allergy

March 5 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * ASIT BIOTECH REVEALS THE MODE OF ACTION OF ITS LEAD
IMMUNOTHERAPY PRODUCT FOR ALLERGIC RHINITIS, GP-ASIT+™, IN THE
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (JACI)

Source text for Eikon:  urn:newsml:reuters.com:*:nBw2fxQVfa
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on European Medical Solutions SA

See all news